Correlation Between Valneva SE and Dermata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Dermata Therapeutics, you can compare the effects of market volatilities on Valneva SE and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Dermata Therapeutics.

Diversification Opportunities for Valneva SE and Dermata Therapeutics

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Valneva and Dermata is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and Dermata Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Dermata Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 3.27 times less risky than Dermata Therapeutics. The stock trades about -0.36 of its potential returns per unit of risk. The Dermata Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  174.00  in Dermata Therapeutics on August 30, 2024 and sell it today you would lose (64.00) from holding Dermata Therapeutics or give up 36.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Dermata Therapeutics

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Valneva SE and Dermata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Dermata Therapeutics

The main advantage of trading using opposite Valneva SE and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.
The idea behind Valneva SE ADR and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated